MSLN and malignant mesothelioma: The potential of calretinin and mesothelin to discriminate between mesothelioma cases and asbestos-exposed controls has been confirmed in various studies [36–39] and recently, both markers have also been validated for the early detection of malignant mesothelioma [3].